Skip to content

Second-line antiretrovirals - Food interaction study

Evaluation of the steady-state pharmacokinetics of second-line antiretroviral drugs when administered under different meal conditions in HIV-infected Ugandan adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR2010030001953121
Enrollment
15
Registered
2010-03-02
Start date
2010-03-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Antiretroviral drugs administered with a moderate fat meal
Antiretroviral drugs administered with a high fat meal
Antiretroviral drugs administered without food

Sponsors

Infectious Diseases Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. HIV-infected male and non pregnant female adults > 18 and < 65 years of age 2. On ART containing lopinavir/ritonavir (LPV/r) plus 2NRTI with undetectable viremia (most recent HIV-RNA performed over preceding 12 months measuring <400 copies/ml) 3. No use of herbal/traditional medications or other medication known to induce or inhibit cytochrome P450 in previous 2 weeks 4. Ability to provide full written informed consent

Exclusion criteria

Exclusion criteria: 1. Anaemia ( Hemoglobin) 5 times upper limit of normal 3. Evidence of renal impairment ( serum creatinine > 300 ) 4. Severe bacterial or viral infection (requiring hospitalization or parenteral antibiotics within 2 weeks of screening) 5. Vomiting or diarrhoea lasting greater than 2 weeks within one month of screening 6. Refusal to adhere to prescribed meal conditions during administration of LPV/r plus 2 NRTIs

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of antiretroviral drugs when administered under different meal conditions

Countries

Uganda

Contacts

Public ContactMargaret Denty

Regulatory Affairs Officer

mdenty@idi.co.ug(256) 414 307319

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026